Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cumulus Media A | CMLS | Nov 26, 2024 | 0.69 | -1.72 |
Curbline Properties | CURB | Nov 26, 2024 | 24.35 | 0.00 |
Curevac N.V. | CVAC | Nov 26, 2024 | 2.74 | -1.08 |
CuriosityStream | CURI | Nov 26, 2024 | 1.83 | +1.67 |
Curis | CRIS | Nov 26, 2024 | 4.03 | -1.95 |
CURRENC Group | CURR | Nov 26, 2024 | 1.70 | 0.00 |
Curtiss-Wright | CW | Nov 26, 2024 | 375.05 | +0.99 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Nov 26, 2024 | 44.62 | +0.56 |
Cushman & Wakefield | CWK | Nov 26, 2024 | 15.23 | +0.40 |
Custom Truck One Source | CTOS | Nov 26, 2024 | 5.80 | -1.36 |
Customers Bancorp | CUBI | Nov 26, 2024 | 56.57 | -1.89 |
Customers Bancorp E Pref | CUBI-E | Nov 26, 2024 | 26.18 | -0.04 |
Customers Bancorp F Pref | CUBI-F | Nov 26, 2024 | 25.78 | -0.04 |
Cutera | CUTR | Nov 26, 2024 | 0.39 | +20.39 |
CVB Financial | CVBF | Nov 26, 2024 | 23.83 | -0.71 |
CVD Equipment | CVV | Nov 26, 2024 | 3.14 | +2.61 |
CVR Energy | CVI | Nov 26, 2024 | 19.14 | -0.73 |
Cvr Partners LP Unit | UAN | Nov 26, 2024 | 70.27 | -1.47 |
CVRx | CVRX | Nov 26, 2024 | 15.30 | -1.48 |
CVS Health | CVS | Nov 26, 2024 | 59.01 | -1.78 |
CXApp A | CXAI | Nov 26, 2024 | 1.52 | +6.29 |
CyberArk Software | CYBR | Nov 26, 2024 | 328.01 | +1.12 |
Cybin | CYBN | Nov 26, 2024 | 10.71 | +0.66 |
Cyclacel Pharmaceuticals | CYCC | Nov 26, 2024 | 0.35 | +2.91 |
Cyclacel Pharmaceuticals Pref | CYCCP | Nov 26, 2024 | 6.94 | 0.00 |
Cyclerion Therapeutics | CYCN | Nov 26, 2024 | 1.36 | -6.21 |
Cyclo Therapeutics | CYTH | Nov 26, 2024 | 0.68 | +0.27 |
Cyngn | CYN | Nov 26, 2024 | 6.39 | -0.47 |
Cytek Biosciences | CTKB | Nov 26, 2024 | 6.41 | -4.19 |
Cytokinetics | CYTK | Nov 26, 2024 | 52.02 | +3.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.